Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromocriptine and Insulin Sensitivity
NL-OMON42270Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of bromocriptine in insulin resistance (IR), obesity and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Difference in insulin sensitivity by timing of bromocriptine administration. Started Oct 2014; status: active, not recruiting.
02
Drugs
bromocriptine
03
Conditions
insulin resistance (IR)obesitytype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON42270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42270.